Sex, Fertility & Contraception: What's Next?
For our October webinar, we brought together five experts to discuss what’s next for Sex, Fertility & Contraception. We will cover a wide range of topics, including:
1) The importance of opening a conversation about Sex, Fertility & Contraception, and breaking taboos;
2) Fundraising and getting investment in sextech and femtech space;
3) Innovative products and solutions that are disrupting the female health tech space;
4) How to tailor your marketing strategy when promoting sextech and female health products and services;
5) How to launch a product in a highly regulated environment such as medtech;
6) How to include more men in conversations around sex, fertility and contraception, and more.
Join us virtually and make sure to prepare your questions for our panelists! Those who have registered for the webinar will receive a link for a video call two days prior to the event.
AGENDA
6:30 - Webinar starts
6.30 - 6.35 - Women of Wearables - 5-minute presentation
6.35 - 6.45 - OCON Healthcare - 5-minute presentation
6.45 - 8.00 - Panel discussion + Q&A
8.00 - Webinar finishes
About our panelists:
Daniela Schardinger, Director of Marketing & Medical Affairs at OCON Healthcare
Daniela Schardinger is an experienced Director of Marketing & Medical Affairs at OCON Healthcare, a women’s health company introducing innovative medical solutions that allow women healthier choices while improving their well-being and quality of life. Ms. Schardinger has over a decade of experience in Marketing & Sales, Medical Affairs and Management in the medical and pharmaceutical industries specializing in women’s health around the globe. Prior to joining OCON Healthcare, Ms. Schardinger built up a Swiss Pharmaceutical Company (Gynial AG) as Managing Director - a Women’s Health Firm focusing on bringing innovative contraceptive solutions for women to the market.
Dr. Lyndsey Harper, Founder and CEO of Rosy
Dr. Lyndsey Harper is the Founder and CEO of Rosy. Rosy is on a mission to create solutions that empower women on their journey toward sexual wellness. The mobile platform helps women improve their intimacy and relationships by connecting women to virtual care, a library of educational content, self-help classes, erotica, and a judgment-free community. Dr. Lyndsey Harper created Rosy to give her patients and women across the world a fun, modern, evidence-based place to find help for low libido. Dr. Harper is an Associate Professor (Affiliated) of Ob/Gyn for Texas A&M College of Medicine, a Fellow of The American Congress of Obstetricians and Gynecologists, and a Fellow of the International Society for the Study of Women's Sexual Health. She has been recognized by Forbes as one of the top women disrupting health tech, as a Top Innovator in Dallas for 2020 and in People Newspapers 20 Under Forty 2020.
Dr. Elise Dallas, Safeguarding and Clinic Lead at Babylon Health
Dr. Elise Dallas is a GP with over 15 years of experience and with a keen interest in technology and its application of this to female health. Elise has been working at Babylon Healthcare for the past 5 years (a digital healthcare provider and is dedicated to their mission to ‘put an accessible and affordable health service in the hands of every person on earth’). With Babylon, Elise has been the GP for ‘Ask the Doctor’ for Netmums, was Clinical Lead for the Women’s Health Product team, and has spoken about innovations in women’s health at events including The Faculty Sexual and Reproductive Health Annual Scientific Meeting most recently. In addition to her work at Babylon, Dr. Elise is a partner of a London GP practice where she ran the LARC clinic and a mother of two young boys. As well as her work in the UK, she has worked in Papua New Guinea in obstetrics and gynecology and in Nepal where she set up and led remote breast cancer clinics. Currently, she is Safeguarding and Clinic Lead at Babylon striving to transgress boundaries and configure a dedicated Women’s Health service, including a LARC and sexual health clinic which are needed now more than ever, given the current pandemic crisis which has caused a severe lack of provision of these services and adversely affected women's health once again.
Mylene Yao, M.D., co-founder and CEO of Univfy
Mylene Yao has led Univfy® from founding through stages of technology invention and commercialization. She is now leading the team to scale Univfy's platform services. Her vision is to combine healthcare AI, fintech, and scientific validation to power women's access to fertility treatments that are safe and highly effective. Mylene has over 20 years of experience in clinical and scientific research in reproductive medicine. Prior to founding Univfy, she was on the faculty at Stanford University, where she led NIH-funded fertility and embryo genetics research, and developed the Univfy® technology with the academic founding team. Univfy is the only A.I. platform in the fertility market that provides scientifically validated, personalized reports to counsel patients about their probability of having a baby with IVF. In collaboration with providers, Univfy has analyzed data from more than 200,000 IVF cycles across diverse demographics to recommend and implement effective treatment paths.
Shardi Nahavandi, co-founder of Pexxi
Architect turned scientist, Shardi Nahavandi has extensive experience in sales, design, and building user-centric products. Previously she was the Commercial Director of a biomedical manufacturing company in the Middle East. Shardi holds 5 degrees, 3 of which are from UCL including healthtech and endocrinology. Shardi is also a co-founder of Pexxi, a precision medicine platform for female health that dismisses the ‘one size fits all’ approach to hormonal medications.
This event is organised by Women of Wearables in partnership with OCON Healthcare.
About OCON Healthcare:
OCON Healthcare’s mission is to introduce innovative medical solutions that allow women healthier choices while improving their well-being and quality of life. OCON develops, manufactures, and commercializes innovative women’s health products based on our IUB™ (IntraUterine Ball) proprietary platform. The IUB™, made of a super-elastic alloy Nitinol, is an ideal carrier for hormone-free contraception and other intrauterine drugs. OCON’s first product, the IUB™ Ballerine®, is a long-term, copper-based hormone-free intrauterine contraceptive already used by more than 95.000 women across 24 countries with high satisfaction rates. The Company is also developing an innovative and disruptive pipeline of products using the IUB™ frame for additional indications including abnormal uterine bleeding.
ABOUT Women of Wearables:
Women of Wearables (WoW) is a leading global organisation aiming to inspire, connect and support women and diverse founders and technologists in wearable tech, fashion tech, smart textiles, IoT, health tech, and VR/AR. With headquarters in London (UK) and more than 20,000 members located around the globe, WoW has become a global movement that supports its growing community through events, mentorship, educational programs, and collaboration with its network of local collaborators and partners. Our members are startup founders, designers, technologists, industry experts, researchers, bloggers, journalists, investors, and many more. Become a member and join our community!